Spinocerebellar ataxia Clinical Trials in Paris
3 recruitingParis, France
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Randomized, Parallel-arm, Double Blind, Placebo-controlled Study to Assess the Efficacy of Fampridine for Patients With Spinocerebellar Ataxia SCA27B Caused by a GAA Expansion in the FGF14 Gene
Spinocerebellar Ataxia 27B (SCA27B)
Assistance Publique - Hôpitaux de Paris70 enrolled9 locationsNCT07185347
Recruiting
Phase 1Phase 2
A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD
Spinocerebellar Ataxia Type 3Spinocerebellar Ataxia Type 1Huntington Disease
Vico Therapeutics B. V.68 enrolled14 locationsNCT05822908
Recruiting
Biomarker Research in Inherited Movement Disorders
Spinocerebellar AtaxiasInherited Movement DisordersHyperkinetic Disorders
Assistance Publique - Hôpitaux de Paris4,000 enrolled1 locationNCT05034172